Mervi Laakso

Summary

Country: Finland

Publications

  1. ncbi Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer
    Mervi Laakso
    Department of Pathology, Seinajoki Central Hospital, Seinajoki, Finland
    Clin Cancer Res 12:4185-91. 2006
  2. ncbi Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
    Mervi Laakso
    Department of Pathology, Seinajoki Central Hospital, Seinajoki, Finland
    Mod Pathol 18:1321-8. 2005
  3. ncbi Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours
    M Laakso
    Department of Pathology, Seinajoki Central Hospital, Hanneksenrinne 7, 60220 Seinajoki, Finland
    J Pathol 210:3-9. 2006
  4. ncbi Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry
    Henrik O Helin
    Institute of Medical Technology, University of Tampere, Tampere, Finland
    J Urol 175:495-9. 2006
  5. ncbi Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma
    Sofia K Gruvberger Saal
    Department of Oncology and Theoretical Physics, Lund University, Lund, Sweden
    Clin Cancer Res 13:1987-94. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer
    Mervi Laakso
    Department of Pathology, Seinajoki Central Hospital, Seinajoki, Finland
    Clin Cancer Res 12:4185-91. 2006
    ..Based on variable basal cytokeratin immunostaining patterns, we hypothesized that the "basal phenotype" tumor group may comprise more than one biological entity...
  2. ncbi Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
    Mervi Laakso
    Department of Pathology, Seinajoki Central Hospital, Seinajoki, Finland
    Mod Pathol 18:1321-8. 2005
    ..These results suggest that CK5/14-positive sporadic breast cancers arise from glandularly committed progenitor cells rather than true CK8/18-negative basal cells...
  3. ncbi Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours
    M Laakso
    Department of Pathology, Seinajoki Central Hospital, Hanneksenrinne 7, 60220 Seinajoki, Finland
    J Pathol 210:3-9. 2006
    ..It is concluded that dual-colour CISH, which is a new alternative to FISH enables the assessment of copy number ratio (HER-2/17 centromere) in conjunction with proper histopathological evaluation and the ease of bright-field microscopy...
  4. ncbi Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry
    Henrik O Helin
    Institute of Medical Technology, University of Tampere, Tampere, Finland
    J Urol 175:495-9. 2006
    ....
  5. ncbi Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma
    Sofia K Gruvberger Saal
    Department of Oncology and Theoretical Physics, Lund University, Lund, Sweden
    Clin Cancer Res 13:1987-94. 2007
    ..The aim of the present study was to elucidate the biology and prognostic role of the second ER, ERbeta, in patients treated with adjuvant tamoxifen...